Celebrex Combined With Omeprazole To Reduce Gastrointestinal Adverse Reactions Caused By Celebrex Alone In Treating Chinese Elderly Patients With Osteoarthritis

Junke Li,Wei Chen,Shengjin Ge,Xiaomin Ling,Linghui Jiang

2016-01-01

Abstract:Objective: To investigate the effects of Celebrex combined with omeprazole in treating elderly osteoarthritis (OA) patients with a high risk of gastrointestinal (GI) adverse reactions, indicated by a history of gastroduodenal ulcer or concurrent usage of aspirin, anticoagulants and corticosteroids. Methods: From April 2013 to April 2014, 400 patients (60-75 years old) were divided into 2 groups at a ratio of 1:1. The intervention group was treated with Celebrex (200 mg, bid) combined with omeprazole (20 mg, qd), and the control group was given Celebrex (200 mg, bid) and placebo (1 tablet, qd). The patients were treated continuously for 3 months and evaluated by follow-up every 2 weeks. Arthritic pain was measured using the visual analogue scale (VAS); GI symptoms and platelet adverse reactions were also recorded. Results: 35 patients (17.9%) in the control group dropped out the therapy due to adverse events; 18 patients (9.2%) dropped out of the intervention group with the difference being statistically significant (P = 0.040), which means that the combination regime increased the patients' tolerance to GI adverse reactions. In the control group, common GI adverse events were: 22, dyspepsia (11.2%); 21, abdominal pain (10.7%); 16, diarrhea (8.2%). The incidence of adverse events was obviously reduced in the intervention group, which included: 9, dyspepsia (4.6%); 8, abdominal pain (4.1%); 13, diarrhea (6.7%). The incidence of dyspepsia, abdominal pain and nausea were significantly different (P<0.05). Conclusion: A combination of Celebrex and omeprazole significantly reduced the incidence of GI adverse reactions in Chinese OA patients.